Adaptin Bio (APTN) Total Debt (2022 - 2024)

Adaptin Bio (APTN) has 3 years of Total Debt data on file, last reported at $1.2 million in Q4 2024.

• For the quarter ending Q4 2024, Total Debt rose 12387.08% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2024 stood at $1.2 million (up 12387.08% YoY), and the FY2024 full-year result was $1.2 million, up 12387.08% from the prior year.
• Total Debt grew to $1.2 million in Q4 2024, from $31000.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $1.2 million in Q4 2024 to a low of $5000.0 in Q4 2022.
• A 3-year average of $203275.3 and a median of $28000.0 in 2024 frame the typical range for Total Debt.
• Peak annual rise in Total Debt reached 12387.08% in 2024, while the deepest fall reached 63.16% in 2024.
• Tracing APTN's Total Debt over 3 years: stood at $5000.0 in 2022, then surged by 100.0% to $10000.0 in 2023, then soared by 12387.08% to $1.2 million in 2024.
• Business Quant data shows APTN's Total Debt at $1.2 million in Q4 2024, $31000.0 in Q3 2024, and $28000.0 in Q2 2024.